转移性细胞癌的二线系统疗法:当前见解和未来方向
Isaac E Kim1, Vivian Wong2, Karie Runcie3
1Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
概括
转移性细胞癌 (mRCC) 的二线疗法在初始治疗失败后提供了新的选择. 然而,改善mRCC患者的生存率和生活质量需要持续的研究和临床试验.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 细胞癌 (RCC) 的发生率正在上升,许多患者被诊断为转移性疾病 (mRCC).
- 在第一线免疫检查点抑制剂 (ICI) 和血管内皮生长因子受体 (VEGFR) 氨酸激酶抑制剂 (TKI) 后,病情进展的mRCC患者的预后不佳.
研究的目的:
- 审查目前对mRCC的二线全身疗法.
- 讨论新的疗法和正在进行的临床试验在mRCC治疗.
主要方法:
- 对mRCC的临床试验和治疗选择的文献综述.
- 对各种二线治疗的作用机制的分析.
主要成果:
- 有几种二线疗法可用,包括TKI,mTOR抑制剂,ICI和HIF-2α抑制剂.
- 目前正在进行的试验正在探索新的药物,如贝尔祖提凡,伦瓦提尼布,卡博桑提尼布和谷氨酸酶抑制剂.
结论:
- 最近的临床试验扩大了在一线治疗中进展的mRCC患者的治疗选择.
- 有限的生存结果和生活质量需要在mRCC治疗中持续创新和参与临床试验.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664


